11-40115595-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001258419.2(LRRC4C):c.698C>T(p.Ala233Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000448 in 1,614,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001258419.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC4C | NM_001258419.2 | c.698C>T | p.Ala233Val | missense_variant | 7/7 | ENST00000528697.6 | NP_001245348.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC4C | ENST00000528697.6 | c.698C>T | p.Ala233Val | missense_variant | 7/7 | 1 | NM_001258419.2 | ENSP00000437132 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000120 AC: 30AN: 250914Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135576
GnomAD4 exome AF: 0.000473 AC: 692AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.000444 AC XY: 323AN XY: 727242
GnomAD4 genome AF: 0.000204 AC: 31AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.698C>T (p.A233V) alteration is located in exon 2 (coding exon 1) of the LRRC4C gene. This alteration results from a C to T substitution at nucleotide position 698, causing the alanine (A) at amino acid position 233 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at